Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louisa von Baumgarten

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 5, 2018
[Peripheral neuropathy as a side effect of chemotherapy and targeted therapy]Clemens Gießen-Jung, Louisa von Baumgarten
Der Nervenarzt|November 1, 2023
[New treatment strategies for primary lymphoma of the central nervous system]Sabine Seidel, Leon Kaulen, Louisa von Baumgarten
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Synthetic Cell-Based Immunotherapies for Neurologic DiseasesLouisa von Baumgarten, Hans J Stauss, Jan D Lünemann
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 24, 2013
Successful long-term control of lymphomatous meningitis with intraventricular rituximabTobias Birnbaum, Louisa von Baumgarten, Christine Dudel, et al.
Journal of Neuro-Oncology|January 18, 2013
Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiationTobias Birnbaum, Katja Bochmann, Louisa von Baumgarten, et al.
Journal of Neuro-Oncology|May 10, 2012
Rituximab significantly improves complete response rate in patients with primary CNS lymphomaTobias Birnbaum, Elisabeth Anne Stadler, Louisa von Baumgarten, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 25, 2026
The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapyKathrin Gabriel, Lucie Heinzerling, Louisa von Baumgarten, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 17, 2008
Role of cortical spreading depressions for secondary brain damage after traumatic brain injury in miceLouisa von Baumgarten, Raimund Trabold, Serge Thal, et al.
Neurology International|May 30, 2013
Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphomaTobias Birnbaum, Sigrid Langer, Sigrun Roeber, et al.
Deutsches Arzteblatt International|July 13, 2018
The Diagnosis and Treatment of Primary CNS LymphomaLouisa von Baumgarten, Gerald Illerhaus, Agnieszka Korfel, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|July 5, 2018
[Peripheral neuropathy as a side effect of chemotherapy and targeted therapy]Clemens Gießen-Jung, Louisa von Baumgarten
Der Nervenarzt|November 1, 2023
[New treatment strategies for primary lymphoma of the central nervous system]Sabine Seidel, Leon Kaulen, Louisa von Baumgarten
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Synthetic Cell-Based Immunotherapies for Neurologic DiseasesLouisa von Baumgarten, Hans J Stauss, Jan D Lünemann
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 24, 2013
Successful long-term control of lymphomatous meningitis with intraventricular rituximabTobias Birnbaum, Louisa von Baumgarten, Christine Dudel, et al.
Journal of Neuro-Oncology|January 18, 2013
Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiationTobias Birnbaum, Katja Bochmann, Louisa von Baumgarten, et al.
Journal of Neuro-Oncology|May 10, 2012
Rituximab significantly improves complete response rate in patients with primary CNS lymphomaTobias Birnbaum, Elisabeth Anne Stadler, Louisa von Baumgarten, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 25, 2026
The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapyKathrin Gabriel, Lucie Heinzerling, Louisa von Baumgarten, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 17, 2008
Role of cortical spreading depressions for secondary brain damage after traumatic brain injury in miceLouisa von Baumgarten, Raimund Trabold, Serge Thal, et al.
Neurology International|May 30, 2013
Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphomaTobias Birnbaum, Sigrid Langer, Sigrun Roeber, et al.
Deutsches Arzteblatt International|July 13, 2018
The Diagnosis and Treatment of Primary CNS LymphomaLouisa von Baumgarten, Gerald Illerhaus, Agnieszka Korfel, et al.
Pageof 10